MedRx Co., Ltd (4586.T)

JPY 84.0

(-3.45%)

Long Term Debt Summary of MedRx Co., Ltd

  • MedRx Co., Ltd's latest annual long term debt in 2023 was - JPY , down 0.0% from previous year.
  • MedRx Co., Ltd's latest quarterly long term debt in 2024 Q2 was - JPY , down 0.0% from previous quarter.
  • MedRx Co., Ltd reported annual long term debt of - JPY in 2022, down 0.0% from previous year.
  • MedRx Co., Ltd reported annual long term debt of - JPY in 2021, down 0.0% from previous year.
  • MedRx Co., Ltd reported quarterly long term debt of - JPY for 2024 Q2, down 0.0% from previous quarter.
  • MedRx Co., Ltd reported quarterly long term debt of - JPY for 2023 Q3, down 0.0% from previous quarter.

Annual Long Term Debt Chart of MedRx Co., Ltd (2023 - 2019)

Historical Annual Long Term Debt of MedRx Co., Ltd (2023 - 2019)

Year Long Term Debt Long Term Debt Growth
2023 - JPY 0.0%
2022 - JPY 0.0%
2021 - JPY 0.0%
2020 - JPY 0.0%
2019 - JPY 0.0%

Peer Long Term Debt Comparison of MedRx Co., Ltd

Name Long Term Debt Long Term Debt Difference
Pharma Foods International Co., Ltd. 1.23 Billion JPY 100.0%
Takeda Pharmaceutical Company Limited 4476.5 Billion JPY 100.0%
Sumitomo Pharma Co., Ltd. 133.36 Billion JPY 100.0%
Shionogi & Co., Ltd. 8.75 Billion JPY 100.0%
Wakamoto Pharmaceutical Co.,Ltd. - JPY NaN%
Nippon Shinyaku Co., Ltd. 1.15 Billion JPY 100.0%
Kaken Pharmaceutical Co., Ltd. - JPY NaN%
Eisai Co., Ltd. 134.77 Billion JPY 100.0%
Morishita Jintan Co., Ltd. 106 Million JPY 100.0%
Hisamitsu Pharmaceutical Co., Inc. 76 Million JPY 100.0%
Mochida Pharmaceutical Co., Ltd. - JPY NaN%
Fuso Pharmaceutical Industries,Ltd. 7.02 Billion JPY 100.0%
Nippon Chemiphar Co., Ltd. 13.34 Billion JPY 100.0%
Tsumura & Co. 54.37 Billion JPY 100.0%
Kissei Pharmaceutical Co., Ltd. - JPY NaN%
Torii Pharmaceutical Co., Ltd. 22 Million JPY 100.0%
Towa Pharmaceutical Co., Ltd. 189.12 Billion JPY 100.0%
Fuji Pharma Co., Ltd. 11.92 Billion JPY 100.0%
Zeria Pharmaceutical Co., Ltd. 7.94 Billion JPY 100.0%
KYORIN Holdings, Inc. 435 Million JPY 100.0%
Taiko Pharmaceutical Co.,Ltd. 2.74 Billion JPY 100.0%
Daito Pharmaceutical Co.,Ltd. 4.66 Billion JPY 100.0%
SymBio Pharmaceuticals Limited - JPY NaN%
Mizuho Medy Co.,Ltd. - JPY NaN%
Solasia Pharma K.K. 27 Million JPY 100.0%
Modalis Therapeutics Corporation 412.5 Million JPY 100.0%
ASKA Pharmaceutical Holdings Co.,Ltd. 4.5 Billion JPY 100.0%
Sawai Group Holdings Co., Ltd. 66.84 Billion JPY 100.0%
Cyfuse Biomedical K.K. 345 Million JPY 100.0%
Toho Holdings Co., Ltd. 28.16 Billion JPY 100.0%
Koa Shoji Holdings Co.,Ltd. 1.59 Billion JPY 100.0%